Company CareDx, Inc

Equities

CDNA

US14167L1035

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 09:59:06 2024-03-28 am EDT 5-day change 1st Jan Change
10.42 USD -0.90% Intraday chart for CareDx, Inc +4.23% -13.83%

Business Summary

CareDx, Inc. is a precision medicine company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its suite of AlloSeq products includes AlloSeq Tx, AlloSeq cfDNA, AlloSeq HCT, TruSight HLA, Olerup SSP and QTYPE. It develops and provides diagnostic surveillance testing services for various transplant recipients.

Number of employees: 639

Sales per Business

USD in Million2022Weight2023Weight Delta
Testing Services
74.8 %
264 82.0 % 210 74.8 % -20.50%
Patient and Digital Solutions
13.2 %
29 8.9 % 37 13.2 % +28.92%
Product
12.0 %
29 9.1 % 34 12.0 % +14.58%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
94.8 %
308 95.6 % 266 94.8 % -13.63%
Europe
3.6 %
10 3.0 % 10 3.6 % +6.47%
Rest of the World
1.6 %
5 1.5 % 5 1.6 % -3.70%

Managers

Managers TitleAgeSince
Director of Finance/CFO 48 21-07-31
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - -
Director/Board Member 56 12-09-30
Investor Relations Contact - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal 50 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 66 15-03-01
Director/Board Member 68 14-04-07
Director/Board Member 72 19-08-26
Chairman 66 11-10-31
Director/Board Member 67 02-12-31
Director/Board Member 57 19-06-30
Director/Board Member 56 12-09-30
Director/Board Member 72 21-06-30
Director/Board Member 77 21-09-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 51,778,523 50,146,840 ( 96.85 %) 0 96.85 %

Shareholders

NameEquities%Valuation
ARK Investment Management LLC
13.30 %
7,194,722 13.30 % 77 M $
BlackRock Advisors LLC
9.697 %
5,245,692 9.697 % 56 M $
Vanguard Fiduciary Trust Co.
7.615 %
4,119,682 7.615 % 44 M $
Bellevue Asset Management AG
7.310 %
3,954,792 7.310 % 42 M $
Nikko Asset Management Americas, Inc.
5.314 %
2,874,899 5.314 % 31 M $
Nikko Asset Management Americas, Inc.
5.314 %
2,874,899 5.314 % 31 M $
2,796,267 5.169 % 30 M $
D.E. Shaw & Co., Inc.
4.069 %
2,201,221 4.069 % 23 M $
Gagnon Securities LLC
3.875 %
2,096,044 3.875 % 22 M $
Morgan Stanley Investment Management, Inc.
2.917 %
1,578,228 2.917 % 17 M $

Company contact information

CareDx, Inc.

8000 Marina Boulevard

94005, Brisbane

+415 287 2300

http://www.caredx.com
address CareDx, Inc(CDNA)